We investigated indices of cholesterol metabolism (total cholesterol, ABCA1, ABCG1, PD, and cholesterol loading capacity [CLC]) together with clinical outcome and systemic inflammatory status in patients with advanced renal and lung cancer treated with immunotherapy. The gene discussed is ABCA1; the disease is lung cancer.